Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
20.85 HKD | -0.48% | -5.44% | -0.24% |
14/05 | Calliditas Therapeutics Partner Offers Nefecon in China; Shares Rise | MT |
14/05 | Everest Medicines Announces Commercial Launch and First Prescription for NEFECON in Mainland China | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-0.24% | 86Cr | |
+0.82% | 9.19TCr | |
-1.32% | 3.87TCr | |
-12.88% | 3.28TCr | |
+64.77% | 2.67TCr | |
-16.31% | 1.53TCr | |
-5.78% | 1.33TCr | |
-11.38% | 1.17TCr | |
+173.10% | 1.04TCr | |
-49.84% | 1.01TCr |
- Stock Market
- Equities
- 1952 Stock
- News Everest Medicines Limited
- Everest Medicines Commercially Launches Kidney Disease Drug in China